IVF After Removal of One Ovary: What Changes in Stimulation and Retrieval?

An ovary is an independent site of follicle growth. With one remaining ovary, the total pool available for stimulation may be smaller, although the actual response varies considerably. It does not follow that every patient needs double medication, nor that treatment is futile. Age remains important, as do the pathology report from the removed ovary and the underlying condition. Someone whose ovary was removed for an isolated benign problem may need a different approach from someone with extensive endometriosis or prior chemotherapy. A prior pregnancy does not remove the need for current assessment.

Bring the operative note, pathology report, medications, menstrual history and any previous stimulation chart. A fertility clinician may use AMH and antral follicle count to anticipate response, while explaining that they do not independently predict a live birth. Ultrasound is particularly valuable because it shows the actual antral follicles in the remaining ovary and checks for cysts. If the remaining ovary is difficult to reach, its location matters for retrieval planning. It may also be sensible to review tubal or uterine issues so that a planned IVF cycle addresses more than egg number alone.

The doctor selects a stimulation protocol using medical history, age, expected response, risk of side effects and prior cycles. There is no universal injection dose simply because one ovary was removed. Follicle development is followed by ultrasound and, where indicated, hormones. If fewer follicles grow than hoped, the team should explain whether proceeding, adjusting expectations, retrieving, or considering alternatives is reasonable. Ask what would change the plan in advance, including the financial implications of cancellation. Avoid using internet egg-count promises as a benchmark for personal success.

An ovary that has shifted position after surgery can occasionally be less accessible during egg collection. The fertility facility should review pelvic anatomy before scheduling retrieval, especially after extensive adhesions or complications. Ultrasound-guided retrieval involves anaesthesia or sedation planning and cannot be performed at home. Contact the medical team promptly for severe pain, fever, unexpected bleeding or marked bloating during treatment. The ultimate decision about embryo transfer must consider embryo development and uterine health, not only the quantity of eggs collected.

Ask for an expected range of possible responses rather than a guarantee. Request a clear statement of whether conventional IVF, ICSI for a sperm indication, embryo freezing or donor options are being discussed and why. Confirm whether timing matters because of age or a progressive medical condition. If surgery was performed for cancer or a borderline tumour, the treating oncology team must be involved. It is reasonable to seek another opinion if the only explanation offered is that “one ovary means half the chance,” because care decisions need more individual evidence.

The HomeIVF approach combines medical supervision with selected home-supported logistics rather than offering “DIY IVF.” Depending on local availability and the case, patients may discuss investigations by teleconsultation, eligible home blood draws, injection guidance or nursing support. These are aids to a doctor-led treatment plan, not replacements for required ultrasound imaging, physical examination, urgent assessment or laboratory procedures. Egg retrieval, embryo culture, ICSI and embryo transfer all need appropriate facilities. For complex diagnoses especially, convenience must never determine whether a medically necessary visit happens. A written plan should identify the responsible clinician, test-result turnaround process and circumstances requiring in-person review.

A particularly helpful question is what the remaining ovary did during any previous stimulation cycle. If that information exists, it may be more informative than an isolated AMH reading. If the original surgery was for a cyst, ask whether repeat imaging shows recurrence and whether the remaining ovary appears safely accessible. People who have an inherited cancer predisposition or a malignancy-related surgery need advice from the appropriate oncology team. Write down the realistic options if only one follicle develops, including whether to proceed or defer. Knowing the decision points before injections start helps reduce pressure and surprise costs.

A safe plan should also be financially intelligible. Request a stage-by-stage quote, including medication changes, monitoring, specialist referral, anaesthesia or laboratory services if applicable, and what happens if a cycle cannot proceed. Confirm whether future frozen embryo transfers and storage are separate charges. A second opinion is not an obligation to buy another package; it should clarify decisions and help avoid tests or add-ons without a clear indication. If any provider promises a guaranteed result or insists on a deposit before explaining risks, ask for independent clinical advice.

The safest next step is an individualised review of the available records with a qualified fertility clinician and, when needed, a relevant specialist. Ask what is established, what remains uncertain and exactly how a proposed test or treatment would change care. The aim is informed progress, not a guaranteed outcome.